Role of Transglutaminase 2 in Liver Injury via Cross-linking and Silencing of Transcription Factor Sp1

Gastroenterology

Volumn 136, Issue 5, 2009, Pages

  Tatsukawa, Hideki ^a,b   Fukaya, Yayoi ^a   Frampton, Gordon ^c   Martinez Fuentes, Antonio ^c   Suzuki, Kenji ^a   Kuo, Ting Fang ^a   Nagatsuma, Keisuke ^d,e   Shimokado, Kentaro ^b   Okuno, Masataka ^f   Wu, Jian ^c   Iismaa, Siiri ^g,h   Matsuura, Tomokazu ^d,e   Tsukamoto, Hidekazu ^i,j   Zern, Mark A ^c   Graham, Robert M ^g,h   Kojima, Soichi ^a  

^a Chemical Biology Department   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e JIKEI UNIVERSITY HOSPITAL   (Japan)

^f GIFU UNIVERSITY   (Japan)

^g VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^h UNIVERSITY OF NEW SOUTH WALES   (Australia)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYSTAMINE; FAS ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PUTRESCINE; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR SP1;

ALCOHOLIC FATTY LIVER; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVITY; GENE SILENCING; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LIVER CELL; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 65249179547     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.01.007     Document Type: Article

References (26)

1. Ribeiro P.S., Cortez-Pinto H., Solá S., et al. Hepatocyte apoptosis, expression of death receptors, and activation of NF-κB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 99 (2004) 1708-1717
2. Lorand L., and Graham R.M. Transglutaminases: cross-linking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4 (2003) 140-156
3. Fésüs L., and Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27 (2002) 534-539
4. Griffin M., Casadio R., and Bergamini C.M. Transglutaminases: nature's biological glues. Biochem J 368 (2002) 377-396
5. Mirza A., Liu S.L., Frizell E., et al. A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kB. Am J Physiol 272 (1997) G281-G288
6. Antonyak M.A., Jansen J.M., Miller A.M., et al. Two isoforms of tissue transglutaminase mediate opposing cellular fates. Proc Natl Acad Sci U S A 103 (2006) 18609-18614
7. Monsonegro M., Friedmann I., Shani Y., et al. GTP-dependent conformational changes associated with the functional switch between Gα and cross-linking activities in brain-derived tissue transglutaminase. J Mol Biol 282 (1998) 713-720
8. Citron B.A., SantaCruz K.S., Davies P.J., et al. Intron-exon swapping of transglutaminase mRNA and neuronal Tau aggregation in Alzheimer's disease. J Biol Chem 276 (2001) 3295-3301
9. Wu J., Liu S.L., Zhu J.L., et al. Roles of tissue transglutaminase in ethanol-induced inhibition of hepatocyte proliferation and a1-adrenergic signal transduction. J Biol Chem 275 (2000) 22213-22219
10. Nanda N., Iismaa S.E., Owens W.A., et al. Targeted inactivation of Gh/tissue transglutaminase II. J Biol Chem 276 (2001) 20673-20678
11. De Laurenzi V., and Melino G. Gene disruption of tissue transglutaminase. Mol Cell Biol 21 (2001) 148-155
12. Strnad P., Harada M., Siegel M., et al. Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement. Gastroenterology 132 (2007) 1515-1526
13. Nardacci R., Lo lacono O., Ciccosanti F., et al. Transglutaminase type II plays a protective role in hepatic injury. Am J Pathol 162 (2003) 1293-1303
14. Antonyak M.A., Miller A.M., Jansen J.M., et al. Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells. J Biol Chem 279 (2004) 41461-41467
15. Sarang Z., Molnar P., Nemeth T., et al. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice. Hepatology 42 (2005) 578-587
16. Fésüs L., and Szondy Z. Transglutaminase 2 in the balance of cell death and survival. FEBS Lett 579 (2005) 3297-3302
17. Botella L.M., Sanchez-Elsner T., Sanz-Rodriguez F., et al. Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury. Blood 100 (2002) 4001-4010
18. Liu Y. The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization. Gene 215 (1998) 159-169
19. Shimada J., Suzuki Y., Kim S.J., et al. Transactivation via RAR/RXR-Sp1 interaction: characterization of binding between Sp1 and GC box motif. Mol Endocrinol 15 (2001) 1677-1692
20. Peng X., Zhang Y., Zhang H., et al. Interaction of tissue transglutaminase with nuclear transport protein importin-α3. FEBS Lett 446 (1999) 35-39
21. Minagawa M., Deng Q., and Liu Z.X. Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption. Gastroenterology 126 (2004) 1387-1399
22. Han J.A., and Park S.C. Transglutaminase-dependent modulation of transcription factor Sp1 activity. Mol Cells 10 (2000) 612-618
23. Dunah A.W., Jeong H., Griffin A., et al. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296 (2002) 2238-2243
24. Li S.H., Cheng A.L., Zhou H., et al. Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol 22 (2002) 1277-1287
25. Zhai W., Jeong H., Cui L., et al. In vitro analysis of Huntington-mediated transcriptional repression reveals multiple transcription factor targets. Cell 123 (2005) 1241-1253
26. Stabile L.P., Lyker J.S., Huang L., et al. Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy. Gene Ther 11 (2004) 325-335